BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

791 related articles for article (PubMed ID: 15363559)

  • 1. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
    Remzi M; Dobrovits M; Reissigl A; Ravery V; Waldert M; Wiunig C; Fong YK; Djavan B;
    Eur Urol; 2004 Oct; 46(4):451-6. PubMed ID: 15363559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of prostate cancer on repeat transrectal ultrasound-guided systematic prostate biopsy.
    Park SJ; Miyake H; Hara I; Eto H
    Int J Urol; 2003 Feb; 10(2):68-71. PubMed ID: 12588600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of prostate specific antigen density and transrectal ultrasonography-guided biopsies in 100 consecutive patients with a negative digital rectal examination and intermediate serum prostate specific antigen levels.
    Tarcan T; Ozveri H; Biren T; Türkeri L; Akdas A
    Int J Urol; 1997 Jul; 4(4):362-7. PubMed ID: 9256325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced transrectal ultrasonography for the detection of diffuse prostate cancer.
    Gao Y; Liao XH; Lu L; Wang L; Ma Y; Qin HZ; Yan X; Guo P
    Clin Radiol; 2016 Mar; 71(3):258-64. PubMed ID: 26738964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential value of power Doppler ultrasound imaging compared with grey-scale ultrasound findings in the diagnosis of local recurrence after radical prostatectomy.
    Tamsel S; Killi R; Apaydin E; Hekimgil M; Demirpolat G
    Clin Radiol; 2006 Apr; 61(4):325-30; discussion 323-4. PubMed ID: 16546462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of power Doppler ultrasonography for prostate biopsy in men with elevated serum prostate specific antigen levels.
    Ho CC; Khor TW; Singam P; Goh EH; Tan GH; Bahadzor B; Zulkifli MZ
    Clin Ter; 2012; 163(3):211-4. PubMed ID: 22964693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml.
    Kumar V; Jagannathan NR; Kumar R; Thulkar S; Gupta SD; Hemal AK; Gupta NP
    NMR Biomed; 2007 Feb; 20(1):11-20. PubMed ID: 16894640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
    Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
    Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of prostate cancer detection using power doppler imaging in American and Japanese men.
    Okihara K; Miki T; Joseph Babaian R
    J Clin Ultrasound; 2002 May; 30(4):213-21. PubMed ID: 11981930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
    Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
    Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience.
    Ong WL; Weerakoon M; Huang S; Paul E; Lawrentschuk N; Frydenberg M; Moon D; Murphy D; Grummet J
    BJU Int; 2015 Oct; 116(4):568-76. PubMed ID: 25560926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of transrectal power doppler imaging in the detection of prostate cancer.
    Inahara M; Suzuki H; Nakamachi H; Kamiya N; Shimbo M; Komiya A; Ueda T; Ichikawa T; Akakura K; Ito H
    Int Urol Nephrol; 2004; 36(2):175-80. PubMed ID: 15368688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does transrectal color Doppler ultrasound improve the diagnosis of prostate cancer?
    Del Rosso A; Di Pierro ED; Masciovecchio S; Galatioto GP; Vicentini C
    Arch Ital Urol Androl; 2012 Mar; 84(1):22-5. PubMed ID: 22649956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies.
    Loch T
    World J Urol; 2007 Aug; 25(4):375-80. PubMed ID: 17694312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, biochemical and pathological features of initial and repeat transrectal ultrasonography prostate biopsy positive patients.
    Yuen JS; Lau WK; Ng LG; Tan PH; Khin LW; Cheng CW
    Int J Urol; 2004 Apr; 11(4):225-31. PubMed ID: 15028101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple vesico-urethral biopsies following radical prostatectomy: the predictive roles of TRUS, DRE, PSA and the pathological stage.
    Scattoni V; Roscigno M; Raber M; Montorsi F; Da Pozzo L; Guazzoni G; Freschi M; Rigatti P
    Eur Urol; 2003 Oct; 44(4):407-14. PubMed ID: 14499673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrasound-guided biopsy: screening of prostate cancer with a single set of 14 systematic biopsies].
    Perdonà S; De Sio M; Damiano R; Oliva A; D'Armiento M
    Arch Ital Urol Androl; 2000 Dec; 72(4):258-63. PubMed ID: 11221051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value and limitations of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer.
    Zhao HX; Xia CX; Yin HX; Guo N; Zhu Q
    Eur J Radiol; 2013 Nov; 82(11):e641-7. PubMed ID: 23916578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
    Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
    BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.